
    
      40 melasma affected women will be included and randomized in two parallel groups (one group
      protected by a UVA+UVB+visible extended sunscreen and one group group protected by a UVA+UVB
      sunscreen).

      There will be 3 visits: Baseline, T2.5months and T5months (final visit).

      Products application frequency: twice daily(morning and afternoon) and additional
      applications every 2 hours in case of solar exposure.

      Main evaluation criterion: the MASI score assessed from standardized photographs (system
      VISIA, Canfield Scientific, USA) at Baseline, middle and end of study.
    
  